drugset / Trial / NCT00625209

Activated Protein C and Corticosteroids for Human Septic Shock

NCT00625209

RandomizedFactorialQuadruple-blindTreatment

Summary

This study aims at comparing the efficacy and safety of recombinant human activated protein C to that of low dose of corticosteroids and at investigating the interaction between these drugs in the management of septic shock

Timeline

Start
2008-03
Primary completion
2015-06
Completion
2016-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Drotrecogin alfa (activated) Protein / enzyme biologic 24 ug/kg Other
Comparator Fludrocortisone Other / unclassified 50 ug Other
Comparator Hydrocortisone Other / unclassified 50 mg Intravenous